Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT
Background: VITT has emerged as a rare but serious adverse event linked primarily to adenoviral vector COVID-19 vaccinations, such as ChAdOx1-S (Oxford/AstraZeneca) vaccination. The syndrome is characterized by thrombosis with thrombocytopenia, elevated D-dimer, and pathologic platelet factor 4 anti...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2025-01-01
|
| Colecção: | Research and Practice in Thrombosis and Haemostasis |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2475037925000019 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
